FDA Approved: BIMZELX — Original Application (UCB, Inc.)

View source ↗

Summary

FDA approved BIMZELX (bimekizumab) from UCB, Inc. via an original biologics license application, marking the first approval of this monoclonal antibody for a ps…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• BIMZELX (BIMEKIZUMAB)

Snippet

ORIG AP for BIMZELX (BIMEKIZUMAB)